Breaking News, Promotions & Moves

Mosaic Therapeutics Taps Thomas Fuchs as CEO

Fuchs has over 25 years’ experience in leadership positions across early drug development, commercialization and life cycle management.

Author Image

By: Charlie Sternberg

Associate Editor

Mosaic Therapeutics Ltd, an oncology therapeutics company, has appointed Thomas Fuchs as CEO. Fuchs will lead the company to advance its pipeline of proprietary drug combination programs into the clinic, and through a planned Series B financing round. “We are delighted to welcome Thomas to Mosaic,” said Edward Hodgkin, Chair of Mosaic’s Board of Directors. “He brings a wealth of oncology therapeutic development and commercialization expertise to Mosaic, alongside a proven track record of buil...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters